tm
Seeing Is Believing
tm
Seeing Is Believing
Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 14 price targets and 33 ratings on display.
Analysts average stock forecasts to be materialized ratio is 44.44% with an average time for these price targets to be met of 432.33 days.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 23-Jul-2023. First documented stock forecast 08-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$48
$46.96 (4515.38%)
2 years 11 months 14 days ago
(23-Jul-2023)
1/2 (50%)
$33.48 (230.58%)
89
Buy
3 years 11 months ago
(07-Aug-2022)
0/2 (0%)
$4172.4 (398.28%)
Buy
$13
3 years 11 months 3 days ago
(04-Aug-2022)
2/2 (100%)
$-34.55 (-72.66%)
291
Hold
4 years 1 months 20 days ago
(17-May-2022)
1/2 (50%)
$-541.2 (-59.07%)
580
Hold
4 years 1 months 20 days ago
(17-May-2022)
1/2 (50%)
$1481.4 (84.24%)
2101
What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the current lower performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?
